Myriad Genetics Inc (NASDAQ:MYGN)

33.14
Delayed Data
As of Feb 23
 +0.44 / +1.35%
Today’s Change
17.50
Today|||52-Week Range
41.57
-3.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line176.2M80.2M125.3M21.8M
 
 
 
 
 
Depreciation13.8M25.0M26.7M48.3M
 
 
 
 
 
Total Other Cash Flow52.0M76.4M61.6M71.4M
 
 
 
 
 
Funds From Operations250.2M181.2M231.7M142.8M
 
 
 
 
 
Funds From/For Other Operating Expenses60.0M40.7M65.4M36.6M
 
 
 
 
 
Net Cash Flow - Operating Activities190.2M140.5M166.3M106.2M
 
 
 
 
 
 
InvestingIncrease In Investments-385.3M-100.8M-164.5M-87.5M
 
 
 
 
 
Decrease In Investments381.9M165.6M115.1M163.4M
 
 
 
 
 
Capital Expenditures-14.3M-23.9M-5.0M-6.1M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-37.0M-216.1M
 
 
 
Net Cash Flow Investing-17.7M40.9M-91.4M-146.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00-1.0M
 
 
Long Term Borrowings0.000.000.00204.0M
 
 
Long Term Debt Reduction0.000.000.00-105.0M
 
 
Net Proceeds Stock Sale64.8M30.0M94.3M6.0M
 
 
 
 
 
Common Preferred Redeemed-287.7M-210.7M-162.6M-31.6M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--3.4M0.000.00
 
 
Other Uses - Financing-11.1M--0.00600.0K
 
 
 
Net Cash Flow - Financing-211.8M-177.3M-68.3M71.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00-4.8M-2.2M2.2M
 
 
 
 
 
Net Change In Cash-39.3M4.1M6.6M31.7M